New Zealand markets closed

Omega Healthcare Investors, Inc. (OHI)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
30.63-0.05 (-0.16%)
At close: 04:00PM EDT
30.64 +0.01 (+0.03%)
After hours: 06:22PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.57B
Enterprise value 12.24B
Trailing P/E 27.35
Forward P/E 10.13
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.98
Price/book (mrq)2.15
Enterprise value/revenue 12.55
Enterprise value/EBITDA 14.56

Trading information

Stock price history

Beta (5Y monthly) 0.90
52-week change 35.55%
S&P500 52-week change 326.49%
52-week high 334.77
52-week low 327.53
50-day moving average 330.90
200-day moving average 331.33

Share statistics

Avg vol (3-month) 31.51M
Avg vol (10-day) 31.49M
Shares outstanding 5247.1M
Implied shares outstanding 6254.54M
Float 8246.15M
% held by insiders 10.36%
% held by institutions 167.09%
Shares short (30 Apr 2024) 411.59M
Short ratio (30 Apr 2024) 48.49
Short % of float (30 Apr 2024) 46.35%
Short % of shares outstanding (30 Apr 2024) 44.69%
Shares short (prior month 28 Mar 2024) 413.42M

Dividends & splits

Forward annual dividend rate 42.68
Forward annual dividend yield 48.75%
Trailing annual dividend rate 32.68
Trailing annual dividend yield 38.74%
5-year average dividend yield 48.32
Payout ratio 4239.29%
Dividend date 315 May 2024
Ex-dividend date 429 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 28.07%
Operating margin (ttm)55.46%

Management effectiveness

Return on assets (ttm)3.46%
Return on equity (ttm)7.62%

Income statement

Revenue (ttm)974.84M
Revenue per share (ttm)4.01
Quarterly revenue growth (yoy)11.50%
Gross profit (ttm)N/A
EBITDA 816.57M
Net income avi to common (ttm)273.6M
Diluted EPS (ttm)1.12
Quarterly earnings growth (yoy)87.40%

Balance sheet

Total cash (mrq)361.77M
Total cash per share (mrq)1.46
Total debt (mrq)5.03B
Total debt/equity (mrq)135.90%
Current ratio (mrq)1.00
Book value per share (mrq)14.26

Cash flow statement

Operating cash flow (ttm)657.85M
Levered free cash flow (ttm)520.2M